If you liked this article you might like

More Squawk From Jim Cramer: Mylan (MYL) Benefited From Few Competitors
U.S. Stocks Rise as Investors Weigh September Rate Hike; Mylan to Offer Generic EpiPen
Stocks Rise as Investors Weigh Possible Rate Hike
Stock Futures Flat as Investors Weigh Possible Rate Hike